Literature DB >> 8333125

Susceptibility of Nigerian west African dwarf and red Sokoto goats to a strain of Trypanosoma congolense.

M I Adah1, E B Otesile, R A Joshua.   

Abstract

West African Dwarf (WAD) and Red Sokoto (RS) goats were experimentally infected with the Kafanchan strain of Trypanosoma congolense and the course of the infection was monitored. The organism was pathogenic and produced fatal disease in the goats, which was characterized by rapid progressive anaemia, leucocytosis, weight loss and death. All RS goats died within 11 days of infection, and had a mean reduction in packed cell volume (PCV) of 11%. In West African Dwarf goats, one death occurred on Day 13 post-infection with a mean drop in PCV of 9%. Statistically significant (P < 0.05) mean reductions in values of PCV, haemoglobin and red blood cell counts were observed between the infected and control animals of both breeds, and also between the infected WAD and infected RS goats. The anaemia produced was macrocytic. Leucocytosis characterized by neutropenia and lymphocytosis was observed among infected WAD goats, but leucopenia characterized by neutrophilia and lymphopenia was observed in infected RS goats. Infected WAD goats recorded some positive unit weight gain in spite of the infection. It was concluded that the RS breed of goats is more susceptible to T. congolense infection than the WAD breed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333125     DOI: 10.1016/0304-4017(93)90020-n

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

1.  Susceptibility of three breeds of Ugandan goats to experimental infection with Trypanosoma congolense.

Authors:  E Katunguka-Rwakishaya; M Murray; P H Holmes
Journal:  Trop Anim Health Prod       Date:  1997-02       Impact factor: 1.893

2.  A non-cytosolic protein of Trypanosoma evansi induces CD45-dependent lymphocyte death.

Authors:  Nicolas Antoine-Moussiaux; Anne Cornet; François Cornet; Stéphanie Glineur; Martin Dermine; Daniel Desmecht
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.